pH Pharma Develops New Drugs through Synergy between US and Korea

  • Sanjeev Satyal, Head of R&D of pH Phama
  • Implement new technology and culture from U.S.
  • Basic research for new drug candidate in Korea
  • Developing glaucoma and NASH treatments

(For more information, please refer to the link below)

https://www.hankyung.com/it/article/202003033648i